|
MTHFD2L expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.336500E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.984700E-03 |
| Normal-vs-Stage2 |
1.432020E-01 |
| Normal-vs-Stage3 |
2.300600E-03 |
| Normal-vs-Stage4 |
1.175890E-03 |
| Stage1-vs-Stage2 |
9.033600E-01 |
| Stage1-vs-Stage3 |
2.685400E-01 |
| Stage1-vs-Stage4 |
1.129810E-01 |
| Stage2-vs-Stage3 |
5.139200E-01 |
| Stage2-vs-Stage4 |
2.986000E-01 |
| Stage3-vs-Stage4 |
5.245200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.057680E-03 |
| Normal-vs-AfricanAmerican |
7.204300E-02 |
| Normal-vs-Asian |
1.783640E-02 |
| Caucasian-vs-AfricanAmerican |
9.127800E-01 |
| Caucasian-vs-Asian |
6.058800E-01 |
| AfricanAmerican-vs-Asian |
8.767800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.235200E-03 |
| Normal-vs-Female |
6.364300E-03 |
| Male-vs-Female |
7.323800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.406340E-02 |
| Normal-vs-Age(41-60Yrs) |
6.160100E-03 |
| Normal-vs-Age(61-80Yrs) |
1.636540E-03 |
| Normal-vs-Age(81-100Yrs) |
8.668200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.083200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.420000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.874360E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.790400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.621600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.314400E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.744000E-01 |
| Classical-VS-Follicular |
2.286400E-01 |
| Classical-VS-Other |
3.491600E-01 |
| Classical-VS-Normal |
1.540050E-02 |
| Tall-VS-Follicular |
9.242400E-01 |
| Tall-VS-Other |
1.771410E-01 |
| Tall-VS-Normal |
1.652090E-02 |
| Follicular-VS-Other |
2.894800E-01 |
| Follicular-VS-Normal |
6.484600E-03 |
| Other-VS-Normal |
9.449800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.455010E-03 |
| Normal-vs-N1 |
2.582000E-01 |
| N0-vs-N1 |
5.776200E-02 |
|
|
